Search

Take Early Action to Prevent or Address Hearing Loss

The annual spotlight on hearing loss by the World Health Organization (WHO) delivers poignant messages to both policy makers and the public in order to stress just how widespread and life-changing hearing loss is.

Signia UK announces partnership with EARWAYS Medical Ltd for distribution

The EarWay® Pro by EARWAYS Medical is now available on the NHS Supply Chain Framework

Soluvos Medical is looking forward to the congress season

The Soluvos team is looking forward to finally meeting readers in person. It has been such a long time! The team will be at the following events

Step change in care – changing the quality of life and supporting the NHS

Up to 500,000 GP appointments could be saved per annum with patient self-referral to audiology practices - easing pressure on the NHS, according to a new report.

Breakthrough tinnitus device Lenire available in three new clinics in Spain

Neuromod has announced that clinically proven tinnitus treatment device, Lenire, is now available in Malaga, Seville and Granada through partnership with medical technology distributor, TRUSBIN.

Soluvos Medical: exclusive A.R.C. Laser partner in the UK from 1 March 2025

Soluvos Medical is delighted to announce that, as of 1 March 2025, they will be the exclusive A.R.C. Laser partner in the UK. Driven by a commitment to clinical excellence and innovation, Soluvos Medical is proud to deliver state-of-the-art laser...

UK clinics providing Lenire tinnitus treatment device double in latest expansion

Neuromod Devices, the medical device company that specialises in tinnitus treatment, has announced they are partnering with four UK clinics to expand the availability of Lenire®, the clinically proven tinnitus treatment device. Tinnitus, which is commonly known as “ringing in...

Neuromod closes €10 million financing to accelerate commercialisation

Neuromod, an Irish medical device company specialising in tinnitus, has closed a €10 million equity financing deal in a Series B fundraising expansion to expand the availability of tinnitus treatment device, Lenire. Financing was oversubscribed and led by existing investors...

Leightons and The Hearing Care Partnership Opens Registration for Groundbreaking New Clinical Conference: Oxygen 2025

Leightons Opticians & Hearing Care is excited to announce that registration is now open for Oxygen 2025, a pioneering clinical conference taking place on the 9th and 10th of May 2025. This highly anticipated event, hosted by the leading independent,...

Neuromod expands availability of Lenire tinnitus treatment device in Europe with 19 new clinical partnerships

Neuromod Devices, the technology company that specialises in medical devices for tinnitus treatment, has announced 19 new clinical partnerships to expand the availability of the Lenire tinnitus treatment device in Europe. This latest expansion will significantly increase the number of...